Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02705755
Recruitment Status : Completed
First Posted : March 10, 2016
Last Update Posted : October 4, 2019
Sponsor:
Information provided by (Responsible Party):
Theravance Biopharma

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 2018
Actual Study Completion Date : December 2018
Certification/Extension First Submitted : August 8, 2019